Stocks making the biggest moves midday: Tellurian, Wynn Resorts, Snap, Walgreens and more

Stocks making the biggest moves midday: Tellurian, Wynn Resorts, Snap, Walgreens and more


Water from a fountain sprays into the air in front of signage for the Wynn Macau casino resort.

David Paul Morris | Bloomberg | Getty Images

Check out the companies making headlines in midday trading Friday:

Tellurian —  The liquified natural gas company (LNG) surged 19.4% after Credit Suisse upgraded Tellurian to outperform, saying LNG prices are high and may continue to be for the foreseeable future.

Wynn Resorts — Shares of the casino and resort operator’s shares advanced 1.1% after an upgrade from Citi to buy from neutral. The bank cited increasing clarity around regulation and Wynn’s licenses in Macao, along with its attractive valuation.

GameStop — GameStop shares gained more than 4% before inching into red after the company said it will seek stockholder approval at its next shareholder meeting to implement a stock split. The company is proposing an increase to 1 billion shares from 300 million.

BlackBerry — BlackBerry shares fell 9.5% after the communications software company reported disappointing cybersecurity revenues for the previous quarter. The company said Thursday that revenues for its cyber came in at $122 million, below a StreetAccount estimate of $126 million.

Snap — The social media giant’s shares rose 3.8% after Piper Sandler reiterated its overweight rating on Snap, saying it sees a “compelling pocket of user growth opportunity” in Mexico, Brazil, Italy and Spain.

Walgreens Boots Alliance — Walgreens dipped 2% after Baird downgraded the stock to neutral from outperform and cuts it price target on the drug store chain. The downgrade comes after the company reported second-quarter earnings that beat consensus estimates, but said it will take time for its health-care investments to pay-off. Investors are also concerned that Walgreens is losing momentum from pandemic traffic.

Chinese EV makers — Chinese electric vehicle makers’ shares were higher after reporting a March surge in car deliveries despite a rise in Covid cases and raw materials costs. Shares of Li Auto and Xpeng each increased about 5%, while Nio added 4%.

Dell — Dell shares fell 2.7% after Goldman Sachs downgraded the computer builder to neutral from buy amid mounting pressure on the PC market. Dell “remains inexpensive compared to its peers, but we see increasing fundamental headwinds hindering this value unlock,” the firm said.

Qualcomm — Shares of the chip stock fell 3.8% after JPMorgan removed Qualcomm from its Analyst Focus list for the month of April. The Wall Street firm cited “near-term challenges relative to consumer spending.”

— CNBC’s Maggie Fitzgerald, Sarah Min, Samantha Subin and Michael Bloom contributed reporting



Source

Kevin Hassett pivots to possible ‘Trump cards’ amid credit card battle with banks
Finance

Kevin Hassett pivots to possible ‘Trump cards’ amid credit card battle with banks

Key Points Kevin Hassett told Fox Business that U.S. banks could voluntarily provide credit cards to underserved Americans. President Donald Trump called for banks to cap credit card interest rates at 10%, an idea that has been roundly rejected by industry executives and their lobbyists this week. At least one major credit card issuer and […]

Read More
Stocks making the biggest moves midday: Novo Nordisk, Vistra, GE Vernova, Regions Financial and more
Finance

Stocks making the biggest moves midday: Novo Nordisk, Vistra, GE Vernova, Regions Financial and more

Check out some of the companies making headlines in midday trading: Novo Nordisk — The maker of the Wegovy obesity treatment jumped more than 4% as sales of its oral weight loss treatment got off to a strong start. In the first week of its launch, about 1.3% of Wegovy prescriptions were for the oral […]

Read More
Stocks making the biggest moves premarket: PNC, ImmunityBio, Coupang & more
Finance

Stocks making the biggest moves premarket: PNC, ImmunityBio, Coupang & more

Check out the companies making headlines before the bell. ImmunityBio — The biotech company rallied 22%, adding to a 30% rally in the previous session that was sparked by strong guidance for its bladder cancer drug Anktiva. ImmunityBio expects full-year revenue for the drug to jump 700%. Coupang — Shares rose more than 3% after […]

Read More